We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.5B
AUM Growth
-$470M
(-0.57%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.85%
Holding
751
New
67
Increased
353
Reduced
251
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$531M |
| 2 |
Microchip Technology
MCHP
|
+$311M |
| 3 |
Check Point Software Technologies
CHKP
|
+$243M |
| 4 |
Sanofi
SNY
|
+$224M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$364M |
| 2 |
Vertiv
VRT
|
+$292M |
| 3 |
FITB
Fifth Third Bancorp
FITB
|
+$274M |
| 4 |
HF Sinclair
DINO
|
+$253M |
| 5 |
TGNA
TEGNA Inc
TGNA
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.6% |
| 2 | Healthcare | 16.65% |
| 3 | Technology | 14.96% |
| 4 | Industrials | 14.22% |
| 5 | Energy | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NEUE
426
DELISTED
NeueHealth
NEUE
| $3.11M | ﹤0.01% |
20,117
-23,523
| -54% | -$5.22M |
|
427
Host Hotels & Resorts
HST
$17.4B
| $3.1M | ﹤0.01% |
159,698
+1,742
| +1% | +$31.4K |
|
|
HSII
428
DELISTED
Heidrick & Struggles
HSII
| $3.04M | ﹤0.01% |
76,894
-4,351
| -5% | -$184K |
|
429
Visa
V
$697B
| $3.02M | ﹤0.01% |
13,604
-132
| -1% | -$28.5K |
|
430
iShares Russell 2000 Value ETF
IWN
$14.5B
| $3.01M | ﹤0.01% |
18,638
-21,129
| -53% | -$3.37M |
|
431
Perella Weinberg Partners
PWP
$1.18B
| $3.01M | ﹤0.01% |
318,307
-3,935
| -1% | -$41.9K |
|
432
Celestica
CLS
$40.3B
| $2.95M | ﹤0.01% |
247,645
+16,704
| +7% | +$197K |
|
|
UMH
433
UMH Properties
UMH
$1.34B
| $2.93M | ﹤0.01% |
119,138
+881
| +0.7% | +$21.2K |
|
434
First Mid Bancshares
FMBH
$1.4B
| $2.92M | ﹤0.01% |
75,742
-933
| -1% | -$38.4K |
|
|
BELFB
435
Bel Fuse Inc Class B
BELFB
$3.57B
| $2.91M | ﹤0.01% |
163,031
-2,073
| -1% | -$30.5K |
|
436
James River Group Holdings
JRVR
$221M
| $2.9M | ﹤0.01% |
117,166
-1,477
| -1% | -$37.7K |
|
|
ONTF
437
DELISTED
ON24
ONTF
| $2.86M | ﹤0.01% |
217,790
+195,962
| +898% | +$2.95M |
|
438
Pure Cycle
PCYO
$259M
| $2.8M | ﹤0.01% |
233,144
-2,940
| -1% | -$36.4K |
|
439
Popular Inc
BPOP
$11.1B
| $2.8M | ﹤0.01% |
34,283
-1,263
| -4% | -$112K |
|
440
Primis Financial Corp
FRST
$398M
| $2.79M | ﹤0.01% |
199,337
-2,371
| -1% | -$35K |
|
441
Orion
OEC
$400M
| $2.77M | ﹤0.01% |
173,312
-2,165
| -1% | -$37.3K |
|
442
Fortive
FTV
$19.5B
| $2.7M | ﹤0.01% |
+58,709
| New | +$2.9M |
|
443
Heritage Insurance Holdings
HRTG
$905M
| $2.69M | ﹤0.01% |
376,164
+60,697
| +19% | +$376K |
|
|
SF
444
Stifel
SF
$12.8B
| $2.62M | ﹤0.01% |
57,768
+1,681
| +3% | +$80.7K |
|
445
Entravision Communication
EVC
$1.01B
| $2.61M | ﹤0.01% |
407,551
+98,217
| +32% | +$610K |
|
446
Abbott
ABT
$187B
| $2.61M | ﹤0.01% |
22,055
-8,707
| -28% | -$1.08M |
|
|
HNGR
447
DELISTED
Hanger Inc.
HNGR
| $2.61M | ﹤0.01% |
142,207
+10,951
| +8% | +$200K |
|
448
AMERISAFE
AMSF
$573M
| $2.58M | ﹤0.01% |
51,918
-671
| -1% | -$34.3K |
|
449
nVent Electric
NVT
$22.9B
| $2.54M | ﹤0.01% |
+72,990
| New | +$2.55M |
|
450
Linde
LIN
$236B
| $2.51M | ﹤0.01% |
7,871
+47
| +0.6% | +$14.5K |
|
Similar funds
Boston Partners's Q1 2022 Portfolio in Review
As of Q1 2022, Boston Partners held 751 positions worth $82.5B, down 0.57% from $83B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q1 2022 filing shows 67 new, 353 increased, 251 reduced and 53 closed positions. Its largest new stake was Microchip Technology: 4,127,908 shares worth $310M. The largest sale was Citigroup, an estimated $364M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2022 buy was Microchip Technology: 4,127,908 shares worth $310M.
- Boston Partners added most to Procter & Gamble in Q1 2022, an estimated $531M increase.
- Boston Partners's biggest Q1 2022 reduction was Citigroup, cutting an estimated $364M.
- Boston Partners fully exited Vertiv in Q1 2022, selling an estimated $292M.
- Boston Partners's ten largest holdings make up 14% of its $82.5B portfolio in Q1 2022.
- Boston Partners opened 67 new positions and closed 53 in Q1 2022.
- Boston Partners's portfolio value fell 0.57% quarter-over-quarter to $82.5B.
Based on Boston Partners's 13F filing for Q1 2022, filed 10 May 2022.